New Meds and Tech from PES Drugs and Therapeutics Committee

Brief Therapeutic Update from PES Drugs and Therapeutics Committee (THYQUIDITYTM) THYQUIDITYTM is a liquid levothyroxine preparation that is FDA approved for (i) treatment of congenital or…

Read More

New Meds and Tech from PES Drugs and Therapeutics Committee

This content is for PES Members.

Log In

Not a member yet? Join the largest Pediatric Endocrine community and unlock a host of tools, resources, and enhance your network! Click here to learn more.

Read More

New Meds and Tech from PES Drugs and Therapeutics committee

Approval of generic glucagon for management of hypoglycemia Prepared by: Kristal Matlock, Preneet Cheema Brar, Molly Regelmann UpToDate as of: 1/20/2021 On December 28, 2020, the…

Read More

New Meds and Tech from PES Drugs and Therapeutics committee

Setmelanotide Prepared by: Anshu Gupta, MD, MS and Brenda Kohn, MD Up-to-date as of December 14, 2020 On November 27, 2020, setmelanotide (IMCIVREE™; Rhythm Pharmaceuticals, Inc.),…

Read More

New Meds and Tech from PES Drugs and Therapeutics committee

Saxenda (Liraglutide) Approved for Adolescent Obesity Prepared by: Laura Page, MD and Shilpa Mehta, MD Up to date as of December 10, 2020 On December 4,…

Read More

New Meds and Tech from PES Drugs and Therapeutics committee

Hydrocortisone Granules (Alkindi Sprinkle) Prepared by: Takara Stanley, Seth Marks and Kyriakie Sarafoglou Up to date as of: November 4, 2020 On September 29, 2020, the…

Read More

New Meds and Tech from PES Drugs and Therapeutics Committee (Liraglutide)

Prepared by: Vandana Raman, Shilpa Mehta, and Amit Lahoti. Last Updated on: 8/11/20 Liraglutide is a long-acting analog of human glucagon-like peptide (GLP)-1. It was approved…

Read More

New Meds and Tech: Burosumab Twza (Crysvita – Ultragenyx Pharmaceuticals)

Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast…

Read More

New Meds and Tech: Semglee

Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc.…

Read More

New Meds and Tech: Freestyle Libre 2

Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system.…

Read More